PCK 6.67% 2.8¢ painchek ltd

Maybe a little tough on CJ there Z.FDA approval is absolutely...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,694 Posts.
    lightbulb Created with Sketch. 253
    Maybe a little tough on CJ there Z.
    FDA approval is absolutely what we want to see, but we all know that (generally speaking) FDA approval is seen as one of the more difficult hurdles to...hurdle.

    PCK seems well positioned to achieve FDA approval based on the information we know, and this USPTO development can maybe assist in this regard.
    Personally I know very little about the specifics of FDA approval processes, so can't really comment further.
    If PCK achieves FDA approval we will see a large increase in the SP, as there is no way that is factored into the SP now, and it will absolutely be a massive achievement for the PCK team.

    As I stated in my previous post, the best thing about today's announcement is that it has greatly increased PCK's chances of being *the only* FDA approved device in this specific market.
    Now that would be huge.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
-0.002(6.67%)
Mkt cap ! $45.84M
Open High Low Value Volume
2.9¢ 2.9¢ 2.8¢ $7.462K 257.5K

Buyers (Bids)

No. Vol. Price($)
5 1209083 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 60000 1
View Market Depth
Last trade - 14.48pm 18/11/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.